52,57,58 Moreover, the effect was consistent across all HRQoL domains (e.g
In rare cases, they may also increase the risk of pancreatitis or gallbladder problems
As the healthcare industry adapts to the evolving needs of diabetic and obese patients, the demand for GLP-1 receptor agonists that offer a range of therapeutic options and flexible dosing schedules is expected to drive market growth further
Some evidence suggests semaglutide may offer cardiovascular benefits, such as reducing the risk of heart attack and stroke in people with diabetes, but individual reactions vary
(This helps explain the somewhat counterintuitive protective effect of obesity against bone fractures and osteoporosis.) This makes strength training and aerobic exercise even more crucial
Limited preclinical research has explored potential interactions between GLP-1 signaling and stress hormone pathways